Published in J Control Release on May 14, 2001
DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J (2005) 2.03
Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys J (2003) 1.50
Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes. J Control Release (2009) 1.12
Physical non-viral gene delivery methods for tissue engineering. Ann Biomed Eng (2012) 1.06
Innovative strategy for microRNA delivery in human mesenchymal stem cells via magnetic nanoparticles. Int J Mol Sci (2013) 0.95
Water-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors. Mol Pharm (2008) 0.94
Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin. J Control Release (2006) 0.92
Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery. J Pharm Sci (2010) 0.87
Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes. Mol Pharm (2013) 0.83
Self-assembled nanoparticles based on modified cationic dipeptides and DNA: novel systems for gene delivery. J Nanobiotechnology (2013) 0.81
Investigation of siRNA Nanoparticle Formation Using Mono-Cationic Detergents and Its Use in Gene Silencing in Human HeLa Cells. Cancers (Basel) (2013) 0.78
A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacol Sin (2010) 0.77
DNA as therapeutics; an update. Indian J Pharm Sci (2009) 0.75
Antitumor cell-complex vaccines employing genetically modified tumor cells and fibroblasts. Toxins (Basel) (2014) 0.75
CRISPR-Cas9 directed knock-out of a constitutively expressed gene using lance array nanoinjection. Springerplus (2016) 0.75
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Review: tissue engineering for regeneration of articular cartilage. Biomaterials (2000) 2.40
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials (1998) 1.69
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
Growth factor delivery for tissue engineering. Pharm Res (2000) 1.42
Biomaterials and bone mechanotransduction. Biomaterials (2001) 1.39
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. Biomaterials (1998) 1.30
In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30
Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules (2001) 1.26
Polymer concepts in tissue engineering. J Biomed Mater Res (1998) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed (2001) 1.24
Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage (2006) 1.24
Review: Hydrogels for cell immobilization. Biotechnol Bioeng (1996) 1.21
Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem (1998) 1.19
Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant (1994) 1.17
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release (2005) 1.14
The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med (2006) 1.12
Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng (2000) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng (1995) 1.11
Growing new organs. Sci Am (1999) 1.10
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. J Biomater Sci Polym Ed (1995) 1.07
Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed (2006) 1.06
Bone tissue engineering. Nat Med (1995) 1.05
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A (2009) 1.05
Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials (1999) 1.05
In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1999) 1.04
Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials (1999) 1.03
Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J Biomater Sci Polym Ed (1999) 1.01
Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res (1994) 1.00
Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant (1997) 0.99
Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng (2000) 0.99
In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials (2000) 0.98
Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res (2000) 0.97
TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am (2001) 0.97
Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res (1997) 0.97
Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J Biomed Mater Res (1997) 0.95
Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater (2010) 0.94
Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release. Biomaterials (1995) 0.93
Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng (1999) 0.92
Characterization of partially saturated poly(propylene fumarate) for orthopaedic application. J Biomater Sci Polym Ed (1997) 0.92
Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res (2000) 0.91
Retinal pigment epithelium engineering using synthetic biodegradable polymers. Biomaterials (2001) 0.91
Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behavior. Eur Cell Mater (2011) 0.90
Degradation and biocompatibility of a poly(propylene fumarate)-based/alumoxane nanocomposite for bone tissue engineering. J Biomed Mater Res A (2007) 0.90
Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A (2008) 0.90
Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplant (1999) 0.89
Modulation of marrow stromal cell function using poly(D,L-lactic acid)-block-poly(ethylene glycol)-monomethyl ether surfaces. J Biomed Mater Res (1999) 0.89
Biodegradable fumarate-based drug-delivery systems for ophthalmic applications. J Biomed Mater Res A (2009) 0.89
Preparation and characterization of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomater Sci Polym Ed (1998) 0.88
Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomater (2011) 0.88
In vitro and in vivo degradation of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1998) 0.87
Poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers control adhesion and osteoblastic differentiation of marrow stromal cells. Tissue Eng (2003) 0.87
Retinal pigment epithelial cell adhesion on novel micropatterned surfaces fabricated from synthetic biodegradable polymers. Biomaterials (2001) 0.86
In vivo degradation of calcium phosphate cement incorporated into biodegradable microspheres. Acta Biomater (2009) 0.85
Integrin alpha(v)beta(3) is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet-derived growth factor. J Cell Biochem (2001) 0.85
Retinal pigment epithelium cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1997) 0.83
Preparation of macroporous poly(2-hydroxyethyl methacrylate) hydrogels by enhanced phase separation. Biomaterials (2000) 0.83
Synthetic biodegradable polymers for orthopaedic applications. Clin Orthop Relat Res (1999) 0.82
Osseointegration of preformed polymethylmethacrylate craniofacial prostheses coated with bone marrow-impregnated poly (DL-lactic-co-glycolic acid) foam. Plast Reconstr Surg (1999) 0.82
Cell seeding in porous transplantation devices. Biomaterials (1993) 0.82
Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers. J Control Release (2006) 0.80
Guided bone growth in sheep: a model for tissue-engineered bone flaps. Tissue Eng (1996) 0.80
Retinal pigment epithelial cell function on substrates with chemically micropatterned surfaces. Biomaterials (1999) 0.80
PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics. J Biomater Sci Polym Ed (2008) 0.80
Effect of macromer molecular weight on in vitro ophthalmic drug release from photo-crosslinked matrices. Acta Biomater (2007) 0.79
Intra-articular microparticles for drug delivery to the TMJ. J Dent Res (2010) 0.79
Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro. Biomaterials (1998) 0.79
Retinal pigment epithelium cell culture on thin biodegradable poly(DL-lactic-co-glycolic acid) films. J Biomater Sci Polym Ed (1998) 0.78
An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2. J Cell Biochem (2001) 0.77
Manufacture and characterization of poly(alpha-hydroxy ester) thin films as temporary substrates for retinal pigment epithelium cells. Biomaterials (1996) 0.77
Injectable, in situ forming poly(propylene fumarate)-based ocular drug delivery systems. J Biomed Mater Res A (2007) 0.77
Dynamics of fibrovascular tissue ingrowth in hydrogel foams. Cell Transplant (1995) 0.75
Osteoblast migration on poly(alpha-hydroxy esters). Biotechnol Bioeng (1996) 0.75
Cells for drug delivery platforms. Adv Drug Deliv Rev (2000) 0.75
Cardiovascular gene transfer. Tissue Eng (1995) 0.75
The growth and phenotypic expression of human osteoblasts. Cytotechnology (1996) 0.75
Preparation and Use of Porous Poly(α-Hydroxyester) Scaffolds for Bone Tissue Engineering. Methods Mol Med (1999) 0.75
Diffusion-controlled delivery of proteins from hydrogels and other hydrophilic systems. Pharm Biotechnol (1997) 0.75
Matrix modifications modulate ophthalmic drug delivery from photo-cross-linked poly(propylene fumarate)-based networks. J Biomater Sci Polym Ed (2009) 0.75
Biomaterials for tissue engineering: summary. Tissue Eng (1997) 0.75
Letter from the editors. Tissue Eng (1995) 0.75